cifenline has been researched along with Myocardial Ischemia in 2 studies
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffmeister, HM | 1 |
| Beyer, ME | 1 |
| Seipel, L | 1 |
| Aupetit, JF | 1 |
| Timour, Q | 1 |
| Larbre, JP | 1 |
| Loufoua-Moundanga, J | 1 |
| Kioueh, I | 1 |
| Lopez, M | 1 |
| Faucon, G | 1 |
2 other studies available for cifenline and Myocardial Ischemia
| Article | Year |
|---|---|
Effects of the Na+ antagonist cibenzoline on left ventricular function of postischemic hearts.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Output; Coronary Circulation; Disease Model | 1995 |
Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Electrocardiography; | 1993 |